Methods and compositions for treating or preventing cancer

Details for Australian Patent Application No. 2006236637 (hide)

Owner Schering Corporation

Inventors Wang, Yan; Bishop, Walter R.; Wang, Yaolin; Pachter, Jonathan A.; Liu, Ming

Agent Griffith Hack

Pub. Number AU-B-2006236637

PCT Pub. Number WO2006/113483

Priority 60/671,654 15.04.05 US

Filing date 14 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 6 September 2012

International Classifications

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 31/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/38 - having sulfur as a ring hetero atom

A61K 31/4745

A61K 31/665 - having oxygen as a ring hetero atom, e.g. fosfomycin

A61K 31/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113483 Priority application(s): WO2006/113483

6 September 2012 Application Accepted

  Published as AU-B-2006236637

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236649-Methods and compositions for modulating and detecting WISP activity

2006236633-Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy